Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rejish K Thomas

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
SAGE Open Medical Case Reports|September 15, 2018
Treating electroconvulsive therapy-induced mania with more electroconvulsive therapy: Evidence for electroconvulsive therapy as the ultra-mood stabilizerRejish K Thomas, Patrick J White, Serdar Dursun
Journal of Psychopharmacology (Oxford, England)|September 6, 2018
Rapid effectiveness of intravenous ketamine for ultraresistant depression in a clinical setting and evidence for baseline anhedonia and bipolarity as clinical predictors of effectivenessRejish K Thomas, Glen Baker, John Lind, et al.
Therapeutic Advances in Psychopharmacology|March 4, 2017
Lactate in the brain: an update on its relevance to brain energy, neurons, glia and panic disorderLaurel Riske, Rejish K Thomas, Glen B Baker, et al.
Therapeutic Advances in Psychopharmacology|May 23, 2020
Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkersDmitriy Matveychuk, Rejish K Thomas, Jennifer Swainson, et al.
Expert Review of Neurotherapeutics|July 9, 2019
Esketamine for treatment resistant depressionJennifer Swainson, Rejish K Thomas, Shaina Archer, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
SAGE Open Medical Case Reports|September 15, 2018
Treating electroconvulsive therapy-induced mania with more electroconvulsive therapy: Evidence for electroconvulsive therapy as the ultra-mood stabilizerRejish K Thomas, Patrick J White, Serdar Dursun
Journal of Psychopharmacology (Oxford, England)|September 6, 2018
Rapid effectiveness of intravenous ketamine for ultraresistant depression in a clinical setting and evidence for baseline anhedonia and bipolarity as clinical predictors of effectivenessRejish K Thomas, Glen Baker, John Lind, et al.
Therapeutic Advances in Psychopharmacology|March 4, 2017
Lactate in the brain: an update on its relevance to brain energy, neurons, glia and panic disorderLaurel Riske, Rejish K Thomas, Glen B Baker, et al.
Therapeutic Advances in Psychopharmacology|May 23, 2020
Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkersDmitriy Matveychuk, Rejish K Thomas, Jennifer Swainson, et al.
Expert Review of Neurotherapeutics|July 9, 2019
Esketamine for treatment resistant depressionJennifer Swainson, Rejish K Thomas, Shaina Archer, et al.
Pageof 1